Clinical Trials Logo

Specific Phobia clinical trials

View clinical trials related to Specific Phobia.

Filter by:

NCT ID: NCT05839431 Recruiting - Clinical trials for Autism Spectrum Disorder

Virtual Reality for Youth Phobias

Start date: July 14, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to examine the effectiveness of virtual reality (VR) delivered exposure therapy for youth with phobias or social anxiety, with and without autism spectrum disorder. The study team is also interested in collecting information to better understand phobias and social anxiety.

NCT ID: NCT05300061 Completed - Specific Phobia Clinical Trials

Values Interventions for Increasing Engagement With What is Feared in Individuals With Specific Phobias

Start date: September 1, 2020
Phase: N/A
Study type: Interventional

Exposure is considered the therapy of choice for specific phobias (SPs). Nevertheless, therapy engagement is extremely limited. SPs are maintained through avoidance of feared stimuli and as such willingness to approach what is feared constitutes a key factor that could explain limited treatment engagement. Values interventions, a key element of acceptance and commitment therapy (ACT), might be one way to increase engagement, yet to this date limited research exists in this area. For the purposes of the current study, two brief values interventions were developed: (a) a personal and (b) a prosocial one. These will be compared to (c) a no-instructions control in increasing willingness to approach and approach behaviour towards phobic stimuli. Ninety participants with flying phobia will be randomly allocated to one of the three groups. To measure willingness to engage with feared stimuli and approach behaviour two behavioural approach tasks using novel technologies (virtual reality), which aimed to expose participants to situations analogous to real life, were developed. Willingness and behavioural approach towards airplanes at a one month follow up will also be assessed. Therefore, it is hypothesised that: 1. Participants in either of the two values intervention groups will have greater willingness to engage and approach behaviour towards feared stimuli compared to those in control, during the study tasks. 2. Participants in either of the two values intervention groups will have greater willingness to engage and approach behaviour towards feared stimuli compared to those in control at follow up. Additionally, as prosocial values provide an evolutionary advantage, the second study aim was to identify if they lead to greater engagement with phobic stimuli compared to personal ones. Therefore, it was also hypothesised that: 3. Participants in the prosocial values group will have greater willingness to engage and approach behaviour towards feared stimuli compared to those in personal values group, both during the study tasks and at follow up. 4. Participants in the prosocial values group will have greater willingness to engage and approach behaviour towards feared stimuli compared to those in personal values group at follow up.

NCT ID: NCT05284435 Completed - Clinical trials for Autism Spectrum Disorder

Internet-Based, Parent-Led Cognitive-Behavioral Therapy for Anxiety in Youth With ASD

Start date: March 28, 2022
Phase: N/A
Study type: Interventional

This study compares the effectiveness of two levels of therapist support for an internet-based, parent-led cognitive behavioral therapy for youth with anxiety and ASD.

NCT ID: NCT05118594 Not yet recruiting - Clinical trials for Major Depressive Disorder

Testing a Precision Psychotherapy System for Low-income Patients

ML_LMIC
Start date: February 2026
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the feasibility of an evidence-based system to recommend core interventions, before the beginning of treatment, to psychotherapists treating low-income patients with depressive or anxiety disorders.

NCT ID: NCT05081323 Not yet recruiting - Anxiety Disorder Clinical Trials

Online Psychological Treatment for Rat Phobia Guided by a Virtual Assistant

Start date: January 2023
Phase: N/A
Study type: Interventional

The research work proposes an exposure treatment through a virtual therapeutic assistant called Thera, that interacts verbally with the patient, to guide and control exposure therapies for phobias to small animals delivered through several channels at the same time that it analyzes the Physiological records of the patient in real-time to determine their emotional state during the intervention. In this study it is proposed to evaluate the efficacy of a self-applied treatment where the virtual assistant allows to gradually guide an exposure treatment for rat phobias, taking advantage of intelligent devices for patient monitoring and being considered to determine the progress of the treatment.

NCT ID: NCT04975854 Recruiting - Anxiety Disorders Clinical Trials

Virtual Reality Exposure Therapy for Acrophobia

Start date: July 13, 2021
Phase: N/A
Study type: Interventional

The aim of this study is to examine the efficacy of virtual reality exposure therapy (VRET) as a treatment for specific phobia (acrophobia). The study will randomly assign 42 participants with acrophobia to one of two conditions: a) the experimental condition (consisting of 3 sessions of virtual reality exposure) or b) a control condition. Both groups will receive short information session about general principles of exposure therapy before the start of the study. After the end of the study, the waitlist group will be invited to attend the short version (one or two-sessions) of the VRET. Both groups will receive a final follow-up questionnaires 2 months after the last session.

NCT ID: NCT04909177 Active, not recruiting - Specific Phobia Clinical Trials

oVRcome Self-guided Virtual Reality for Specific Phobias

oVRcome
Start date: June 2, 2021
Phase: N/A
Study type: Interventional

Specific phobias: fear of flying, heights, spiders, dogs and needles are the extremely common and exposure therapy (ET) is the first line of treatment. Using Virtual Reality (VR), participants will have control in gradual exposure to their fears. oVRcome (https://www.ovrcome.io/ Virtual reality app), is a self-help VRET for specific phobias, that is delivered through a smartphone application (app) in combination with a low cost headset that holds the smartphone and uses 360º video. The investigators hypothesize that oVRcome is effective in reducing specific phobia symptoms.

NCT ID: NCT04737915 Completed - Anxiety Disorder Clinical Trials

Virtual Reality Exposure Versus In Vivo Exposure for Fear of Heights

Start date: June 11, 2018
Phase: N/A
Study type: Interventional

This study randomly assigned 114 participants with significant fear of heights to one of three conditions: a) a single session of virtual reality exposure; b) a single session of in vivo exposure; or c) a control condition. The aim of this study was to compare the efficacy of virtual reality exposure to the efficacy of in vivo exposure or no exposure for participants with significant fear of heights.

NCT ID: NCT04594525 Terminated - Clinical trials for Perinatal Depression

Maternal Telemental Health Interventions in Response to Covid-19*

CoronaVirus
Start date: September 5, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the effectiveness of a telemental health intervention on the mental health of pregnant women during the COVID-19 crisis in Qatar.

NCT ID: NCT04563390 Recruiting - Specific Phobia Clinical Trials

Effectiveness of a Projection-based Augmented Reality Exposure System in Treating Cockroach Phobia.

Start date: November 1, 2020
Phase: N/A
Study type: Interventional

The main aim of this study is to validate and test the clinical effectiveness of the projection-based augmented reality system in cockroach phobia exposure therapy through an RCT that includes three conditions: (i) projection-based augmented reality therapy, (ii) usual treatment (in vivo exposure), (iii) waiting list control. In addition, it is intended to analyze the potential of the eye-tracking technology as a tool for evaluating the clinical effectiveness in cockroach phobia treatment.